|
|
Vaccine Detail
|
Autolgous DC Vaccine Pulsed with Autologous Tumor Homogenate for Metastatic RCC |
| Vaccine Information |
- Vaccine Name: Autolgous DC Vaccine Pulsed with Autologous Tumor Homogenate for Metastatic RCC
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: Recombinant vector vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Immunization Route: Intradermal injection (i.d.)
- Description: This vaccine uses dendritic cells pulsed with autologous tumor homogenate in combination With High Dose-IL2 and immunomodulating radiotherapy for patients with Metastatic RCC. (NCT03226236)
|
| Host Response |
|
|
| References |
NCT03226236: Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC (RENALVax-2) [https://clinicaltrials.gov/study/NCT03226236]
|
|
